All
 

 

Just in:  

You are here: Home»Cotton & Textiles»World»Studies boost hopes for new class of cholesterol medicines

Studies boost hopes for new class of cholesterol medicines

New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The U.S. government will decide this summer whether to allow two of these drugs on the market.

People taking one of these drugs had half the risk of dying or suffering a heart problem compared to others who were given usual care typically one of the statin drugs such as Lipitor or Zocor, doctors found. Many people cannot tolerate statins or get enough help from them, so new medicines are badly needed.

The results are "really impressive and very encouraging" for the new drugs, said one independent expert, Dr Judith Hochman of NYU Langone Medical Center.

The studies were published by the New England Journal of Medicine and discussed at an American College of Cardiology conference in San Diego.

They are fresh analyses from older studies designed to look at how much the drugs lower cholesterol, so they can only suggest that the drugs also lower heart problems, not prove that point.

Copyright United Press of Pakistan, 2015



 



 
Index Closing Chg%
Arrow DJIA 16,528.03 0.69
Arrow Nasdaq 4,776.51 1.07
Arrow S&P 1,927.18 0.84
Arrow FTSE 6,247.94 0.90
Arrow DAX 10,259.46 0.38
Arrow CAC-40 4,652.95 0.47
Arrow Nikkei 18,890.48 1.28
Arrow H.Seng 21,670.58 0.27
Arrow Sensex 26,283.09 0.41





New 2015 adidas and Nike Soccer Cleats at Kicks Corner uk



Banking Review 2014


Annual2013/14
Foreign Debt $62.649bn
Per Cap Income $1,512
GDP Growth 4.24%
Average CPI 8.6%
MonthlyJune
Trade Balance $-2.378 bln
Exports $2.016 bln
Imports $4.394 bln
WeeklyAugust 27, 2015
Reserves $18.509 bln